Loading…
Loading…
Series A & B. Growth stage. Before the crowd arrives.
An AIF Category II fund targeting high-growth Indian startups at Series A and Series B — the inflection point between survival and scale. Morphosis provides patient capital to businesses with proven product-market fit and a clear path to profitability.
Min. Investment
₹1 Crore
Risk
Very High
Lock-in
5+1+1 years
The value creation curve in private markets peaks between Series A and pre-IPO. Morphosis enters at Series A/B — after product-market fit is established but well before public markets can participate — capturing the compounding that happens as businesses scale from ₹10Cr to ₹500Cr in revenue.
What is the lock-in period?
5 years with an option to extend to 7 years at the discretion of the Investment Manager. AIF Category II funds are closed-ended by nature — liquidity comes from exits (acquisitions, IPOs, secondary sales), not from redemptions.
What is a hurdle rate?
The hurdle rate is the minimum return (10% p.a. in this case) that limited partners must earn before the fund manager receives any carried interest. If returns fall below the hurdle, the manager earns only the management fee.
How is an AIF different from a mutual fund?
AIFs have a minimum investment of ₹1Cr, are closed-ended, invest in private/unlisted assets using strategies unavailable to mutual funds, and carry significantly higher risk and illiquidity. They are not regulated under the same SEBI (MF) rules.
Can NRIs invest?
Yes, via NRE/NRO route under FEMA regulations. Repatriation rules and DTAA treaty benefits depend on your country of tax residency. We recommend consulting a cross-border tax specialist.
Investments are subject to market risk. Please read all scheme-related documents carefully. Past performance is not indicative of future results.
Have questions about Morphosis? Mavericks Wealth advisors offer a free 30-minute consultation.
Book a free consultation